175 related articles for article (PubMed ID: 8501750)
1. Problems related to systemic glucocorticoid therapy in children.
Melo-Gomes JA
J Rheumatol Suppl; 1993 Apr; 37():35-9. PubMed ID: 8501750
[TBL] [Abstract][Full Text] [Related]
2. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Guillevin L; Holland M; Kirwan JR; Rovensky J; Saag KG; Severijns G; Webber S; Westhovens R; Bijlsma JW
Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma.
Covar RA; Leung DY; McCormick D; Steelman J; Zeitler P; Spahn JD
J Allergy Clin Immunol; 2000 Oct; 106(4):651-9. PubMed ID: 11031335
[TBL] [Abstract][Full Text] [Related]
4. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
Duru N; van der Goes MC; Jacobs JW; Andrews T; Boers M; Buttgereit F; Caeyers N; Cutolo M; Halliday S; Da Silva JA; Kirwan JR; Ray D; Rovensky J; Severijns G; Westhovens R; Bijlsma JW
Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
[TBL] [Abstract][Full Text] [Related]
5. New glucocorticoids on the horizon: repress, don't activate!
Song IH; Gold R; Straub RH; Burmester GR; Buttgereit F
J Rheumatol; 2005 Jul; 32(7):1199-1207. PubMed ID: 16041872
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting growth and strategies for treatment in children after renal transplantation.
Tönshoff B; Mehls O
Pediatr Transplant; 1997 Nov; 1(2):176-82. PubMed ID: 10084778
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
8. [Glucocorticoids in pediatrics].
Radmanović SZ
Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():58-62. PubMed ID: 18193804
[TBL] [Abstract][Full Text] [Related]
9. [Side effects of glucocorticoid therapy and their prevention].
Novikov IuI; Anokhin VN; Stulova MA
Ter Arkh; 1974; 46(9):69-75. PubMed ID: 4548227
[No Abstract] [Full Text] [Related]
10. Uses, adverse effects of abuse of corticosteroids. Part I.
Imam AP; Halpern GM
Allergol Immunopathol (Madr); 1994; 22(6):250-60. PubMed ID: 7892813
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases.
Sanden S; Tripmacher R; Weltrich R; Rohde W; Hiepe F; Burmester GR; Buttgereit F
J Rheumatol; 2000 May; 27(5):1265-70. PubMed ID: 10813299
[TBL] [Abstract][Full Text] [Related]
12. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
[TBL] [Abstract][Full Text] [Related]
13. [Problems in symptomatic therapy of rheumatic diseases with glucocorticoids and nonsteroidal antirheumatic agents].
Mathies H
Internist (Berl); 1979 Sep; 20(9):414-25. PubMed ID: 387649
[No Abstract] [Full Text] [Related]
14. Steroid fears in children with eczema.
Hon KL; Kam WY; Leung TF; Lam MC; Wong KY; Lee KC; Luk NM; Fok TF; Ng PC
Acta Paediatr; 2006 Nov; 95(11):1451-5. PubMed ID: 17062476
[TBL] [Abstract][Full Text] [Related]
15. High dose, alternate day corticosteroids for systemic onset juvenile rheumatoid arthritis.
Kimura Y; Fieldston E; Devries-Vandervlugt B; Li S; Imundo L
J Rheumatol; 2000 Aug; 27(8):2018-24. PubMed ID: 10955346
[TBL] [Abstract][Full Text] [Related]
16. [Glucocorticoids in rheumatic diseases - what is the optimal dose?].
Krause D
Dtsch Med Wochenschr; 2012 Sep; 137(36):1751-4. PubMed ID: 22933199
[TBL] [Abstract][Full Text] [Related]
17. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
18. The safety of low-dose glucocorticoids in rheumatic diseases: results from observational studies.
Hwang YG; Saag K
Neuroimmunomodulation; 2015; 22(1-2):72-82. PubMed ID: 25228230
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of glucocorticoid-associated adverse events.
McDonough AK; Curtis JR; Saag KG
Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741
[TBL] [Abstract][Full Text] [Related]
20. Developments in glucocorticoid therapy.
Bijlsma JW; Saag KG; Buttgereit F; da Silva JA
Rheum Dis Clin North Am; 2005 Feb; 31(1):1-17, vii. PubMed ID: 15639052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
